Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.

MLA

Kuijk, Loes M., et al. “Soluble Helminth Products Suppress Clinical Signs in Murine Experimental Autoimmune Encephalomyelitis and Differentially Modulate Human Dendritic Cell Activation.” Molecular Immunology, vol. 51, no. 2, June 2012, pp. 210–18. EBSCOhost, https://doi.org/10.1016/j.molimm.2012.03.020.

APA

Kuijk, L. M., Klaver, E. J., Kooij, G., van der Pol, S. M. A., Heijnen, P., Bruijns, S. C. M., Kringel, H., Pinelli, E., Kraal, G., de Vries, H. E., Dijkstra, C. D., Bouma, G., & van Die, I. (2012). Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Molecular Immunology, 51(2), 210–218. https://doi.org/10.1016/j.molimm.2012.03.020

Chicago

Kuijk, Loes M, Elsenoor J Klaver, Gijs Kooij, Susanne M A van der Pol, Priscilla Heijnen, Sven C M Bruijns, Helene Kringel, et al. 2012. “Soluble Helminth Products Suppress Clinical Signs in Murine Experimental Autoimmune Encephalomyelitis and Differentially Modulate Human Dendritic Cell Activation.” Molecular Immunology 51 (2): 210–18. doi:10.1016/j.molimm.2012.03.020.